These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21907780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J, Koolen S, Huitema A, Schellens J, Beijnen J, Nuijen B.
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [Abstract] [Full Text] [Related]

  • 3. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T, Puttipipatkhachorn S.
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
    Lim SM, Pang ZW, Tan HY, Shaikh M, Adinarayana G, Garg S.
    Drug Dev Ind Pharm; 2015 Jan; 41(11):1847-55. PubMed ID: 25721984
    [Abstract] [Full Text] [Related]

  • 7. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH, Patel AD, Donahue E, Patel HH.
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [Abstract] [Full Text] [Related]

  • 8. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH, Patel HH, Donahue E, Patel AD.
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [Abstract] [Full Text] [Related]

  • 9. Dispersion of daidzein with polyvinylpyrrolidone effects on dissolution rate and bioavailability.
    Feng BL, Li HW, Zhou MY, Lu W.
    Zhong Yao Cai; 2011 Apr; 34(4):605-10. PubMed ID: 21809547
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.
    de Weger VA, Stuurman FE, Hendrikx JJMA, Moes JJ, Sawicki E, Huitema ADR, Nuijen B, Thijssen B, Rosing H, Keessen M, Mergui-Roelvink M, Beijnen JH, Schellens JHM, Marchetti S.
    Eur J Cancer; 2017 Nov; 86():217-225. PubMed ID: 29031170
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P, Kouwen S, Visser MR, Hinrichs WL, Frijlink HW.
    Pharm Dev Technol; 2010 Nov; 15(5):460-8. PubMed ID: 20735300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I, Liepold B, Rosenberg J, Maegerlein M, Brandl M, Fricker G.
    Eur J Pharm Sci; 2010 Apr 16; 40(1):25-32. PubMed ID: 20172027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.